450
Participants
Start Date
July 1, 2023
Primary Completion Date
August 31, 2025
Study Completion Date
December 31, 2025
Baricitinib 4 MG
Reference drug
St-Luc Clinics, Brussels
Ghent University Hospital, Ghent
Groupe Jolimont, Haine-Saint-Paul
Clinique Saint-Pierre, Ottignies
University Hospital of UCL Namur, Yvoir
CHU Angers, Angers
CHU de Brest, Brest
CHU de Caen, Caen
CHU Clermont-Ferrand, Clermont-Ferrand
CHU de Clermont-Ferrand, Clermont-Ferrand
CHU de Clermont-Ferrand, Clermont-Ferrand
CH La Roche sur Yon, La Roche-sur-Yon
CHU de Limoges, Limoges
CHU de Marseille, Marseille
CHU de Nancy, Nancy
CHU de Nantes, Nantes
CHU de Nantes, Nantes
CHU de Nantes, Nantes
CHU de Nantes, Nantes
CHU de Beaujon, Paris
CHU la Pitié-Salpétrière, Paris
CHU Pitié-Salpétrière, Paris
CHU de Poitiers, Poitiers
CHU de Rennes, Rennes
CHU de Rennes, Rennes
University Medical Center Utrecht, Utrecht
Hospital Clinic, Barcelona
Hospital del Mar, Barcelona
Hospital Vall d'Hebron, Barcelona
Nantes University Hospital
OTHER